Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the bioavailability of a test formulation
of Buprenorphine Naloxone Sublingual (SL) spray to that of a single dose of Suboxone®
(buprenorphine and naloxone) sublingual film, under fasted conditions.
Phase:
Phase 1
Details
Lead Sponsor:
INSYS Therapeutics Inc
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone